VRPX Virpax Pharmaceuticals
- 2.3100
- +0.0700+3.13%
Virpax Pharmaceuticals News
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Virpax Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 10-K: Annual report
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Floyd Eric
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jambulingam Thani
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Singh Vanila
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mathias Sheila
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dubin Michael F
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sendrow Jerrold
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bruce Gerald W
Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ruskin Barbara
Analysis
Price Target
No Data
